A Phase 3, Randomized, Double-Blind, Cross-Over, Active-Controlled Study of the Efficacy and Safety of HPN-100, Glyceryl tri-(4-phenylbutyrate), for the Treatment of Adults with Urea Cycle Disorders
|Effective start/end date||7/6/09 → 6/30/11|
- Hyperion Therapeutics
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.